Babesiosis, unspecified
ICD-10 B60.00 is a billable code used to indicate a diagnosis of babesiosis, unspecified.
Babesiosis is a protozoal infection caused by parasites of the genus Babesia, which are transmitted primarily through the bite of infected Ixodes ticks. This disease is characterized by symptoms such as fever, chills, sweats, headache, body aches, loss of appetite, and nausea. In severe cases, it can lead to hemolytic anemia, thrombocytopenia, and multi-organ failure, particularly in immunocompromised individuals or those without a spleen. The clinical presentation can vary widely, with some patients being asymptomatic while others may experience severe illness. Diagnosis is typically confirmed through blood smear microscopy or serological tests. Treatment usually involves the use of antimalarial medications such as atovaquone combined with azithromycin or clindamycin combined with quinine. Given its association with tick exposure, babesiosis is more prevalent in certain geographic areas, particularly in the northeastern and upper midwestern United States, making awareness and preventive measures crucial for at-risk populations.
Detailed clinical notes including symptom onset, laboratory results, and treatment response.
Patients presenting with fever and recent travel to endemic areas, or those with tick exposure.
Consideration of co-infections and immunocompromised status is crucial for accurate coding.
Comprehensive patient history, including travel and exposure history, and symptom documentation.
Patients with flu-like symptoms and potential tick exposure.
Awareness of local epidemiology of babesiosis and related diseases is important.
Used when a patient presents with symptoms suggestive of babesiosis.
Document the reason for testing and any relevant clinical findings.
Infectious disease specialists may require additional lab results for comprehensive evaluation.
Common symptoms include fever, chills, sweats, headache, body aches, loss of appetite, and nausea. Severe cases may lead to hemolytic anemia and other complications.
Diagnosis is typically made through blood smear microscopy or serological tests that detect antibodies against Babesia.
Treatment usually involves antimalarial medications such as atovaquone combined with azithromycin or clindamycin combined with quinine.
